Lenner P, Lundgren E, Damber L
Acta Radiol Oncol. 1981;20(3):173-85. doi: 10.3109/02841868109130193.
A retrospective analysis of 140 patients with non-Hodgkin's lymphoma in clinical stage I or II classified according to a modified LUKES & COLLINS scheme was performed. Three major groups were found according to cell type, with different clinical features: (1) Small cell lymphomas with a relatively favourable survival in spite of high relapse rates. (2) Large cell lymphomas with lower relapse rates, but short time between relapse and death, and unfavourable survival. (3) Mixed small/large cleaved follicular centre cell lymphoma which was most favourable with respect to relapse and survival. Nodular lymphoma had the same overall relapse rate as diffuse lymphoma, but had a significantly longer survival. Tumours stage I were associated with significantly longer relapse-free survival and survival than stage II. The importance of separating the majority of non-Hodgkin's lymphomas into three main groups according to cell type is emphasized. These major groups require different clinical approaches in terms of staging and treatment.
对140例根据改良的卢克斯和柯林斯方案分类为临床I期或II期的非霍奇金淋巴瘤患者进行了回顾性分析。根据细胞类型发现了三个主要组,具有不同的临床特征:(1)小细胞淋巴瘤,尽管复发率高,但生存率相对较好。(2)大细胞淋巴瘤,复发率较低,但复发与死亡之间的时间较短,生存率不佳。(3)混合性小/大裂细胞滤泡中心细胞淋巴瘤,在复发和生存方面最有利。结节性淋巴瘤的总体复发率与弥漫性淋巴瘤相同,但生存期明显更长。I期肿瘤的无复发生存期和生存期明显长于II期。强调了根据细胞类型将大多数非霍奇金淋巴瘤分为三个主要组的重要性。这些主要组在分期和治疗方面需要不同的临床方法。